Objectives: Cefepime (CFPM) is being used worldwide for febrile neutropenia (FN) with three administrations per day (q8h), but because no population pharmacokinetics analysis has been performed yet, the optimal CFPM administration method remains unknown.
Objectives: Cefepime (CFPM) is being used worldwide for febrile neutropenia (FN) with three administrations per day (q8h), but because no population pharmacokinetics analysis has been performed yet, the optimal CFPM administration method remains unknown.
Methods: We conducted a prospective clinical trial of CFPM among adult hematological patients with FN. CFPM was administered with a daily dose of 4 g (1 g at 10:00, 1 g at 16:00, 2 g at 22:00 hours). NONMEM software was used for the population pharmacokinetic analysis. Monte Carlo simulation was performed based on the data of minimum inhibitory concentration (MIC) frequency distribution of main bacteria strains gathered at our institute.
Results: Intravenous CFPM was administered for 101 episodes of FN. A high percentage of these episodes was treated successfully (69.2%). The NONMEM program demonstrated that a 2-compartment model with CL of 4.23(L/hr), V1 of 12.0(L), Q of 3.98 (L/hr), and V2 of 3.40(L) fits the data best. Monte Carlo simulation indicated that the proportion of simulated patients with probability of attainment above target (time above MIC = 70%) was greater among those treated with the thrice-a-day method than with the twice-a-day method. Time above MIC for administration at irregular time intervals was similar to that for q8h administration.
Conclusions: Our administration method appears to be the most suitable for FN patients. With this method, late night and early morning drip infusion as well as the inconvenience of maintaining exact 8 h intervals can be avoided. doi:10.1016/j.ijid.2008.05.269
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Objective: To explore distribution of qnrA,qnrB,qnrS genes in gram-negative bacteria isolates in Renmin Hospital of Wuhan University.
Methods: qnr genes in nonrepetitive 129 iaolates of E.coli and 13 isolates of E.cloacac and 37 isolates of K. pneunoniae were detected by PCR. Susceptibility test to 15 antibiotics were also performed by K-B in virto. MICs of ciprofloxacin were determined by agar dilution technique. Plasmid conjugatable test was applied to examine whether qnr gene located in conjugatable plasmid or not. IntI were detected by PCR.
Results: Among 179 gram negative bacteria isolates, the qnrA genes were present in 3.88% of E.coli and 7.69% of E.cloaca. The qnrB genes were present in 6.20% of E.coli and 7.69% of E.cloaca. The qnrS genes were present in 2.33% of E.coli and 18.92% of K. pneumoniae. All positive isolates were suspectible to imipenem but resistance to some other drugs. 2 qnrA positive isolates and 4 qnrB positive isolates of were susceptible to ciprofloxacin. Qnr gene were on transferable plasmids and could be dsseminated by clone. 23 of them were I type integron-positive isolates.
Conclusions: In HuBei province, the prevalence of qnr is comfirmed and we find qnr genes could also be in quinolone suspectible strains. So it is necessary to study the prevalence and mechanism of qnr genes of quinolones resistance further in the future. 
